Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome (2012)
- Autores:
- Autores USP: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP
- Unidade: FMRP
- DOI: 10.1097/CCM.0b013e318258fb70
- Assuntos: SOBREVIVÊNCIA CELULAR; QUIMIOTERAPIA (FISIOLOGIA); SENSIBILIDADE E ESPECIFICIDADE; SEPSE (METABOLISMO); MODELOS ANIMAIS DE DOENÇAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Critical Care Medicine
- ISSN: 0090-3493
- Volume/Número/Paginação/Ano: v. 40, n. 9, p. 2631-2637, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TREVELIN, Silvia C. et al. Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome. Critical Care Medicine, v. 40, n. 9, p. 2631-2637, 2012Tradução . . Disponível em: https://doi.org/10.1097/CCM.0b013e318258fb70. Acesso em: 23 abr. 2024. -
APA
Trevelin, S. C., Alves-Filho, J. C., Sônego, F., Turato, W., Nascimento, D. C., Souto, F. O., et al. (2012). Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome. Critical Care Medicine, 40( 9), 2631-2637. doi:10.1097/CCM.0b013e318258fb70 -
NLM
Trevelin SC, Alves-Filho JC, Sônego F, Turato W, Nascimento DC, Souto FO, Cunha TM, Gazzinelli RT, Cunha F de Q. Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome [Internet]. Critical Care Medicine. 2012 ; 40( 9): 2631-2637.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1097/CCM.0b013e318258fb70 -
Vancouver
Trevelin SC, Alves-Filho JC, Sônego F, Turato W, Nascimento DC, Souto FO, Cunha TM, Gazzinelli RT, Cunha F de Q. Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome [Internet]. Critical Care Medicine. 2012 ; 40( 9): 2631-2637.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1097/CCM.0b013e318258fb70 - Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice
- The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone
- Diosmin reduces chronic constriction injury-induced neuropathic pain in mice
- Probucol attenuates lipopolysaccharide-induced leukocyte recruitment and inflammatory hyperalgesia: effect on NF-кB activation and cytokine production
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Pericytes modulate myelination in the central nervous system
Informações sobre o DOI: 10.1097/CCM.0b013e318258fb70 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
